CORC

在结果中检索

CORC

浏览/检索结果: 共29条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Spatially Explicit Large-Scale Environmental Risk Assessment of Pharmaceuticals in Surface Water in China 期刊论文
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2019, 卷号: 53, 期号: 5, 页码: 2559-2569
作者:  Zhu, Ying;  Snape, Jason;  Jones, Kevin;  Sweetman, Andrew
收藏  |  浏览/下载：10/0  |  提交时间：2020/10/21
Final analysis of phase 3 LATITUDE study in patients (pts) with newly diagnosed high-risk metastatic castration-naive prostate cancer (NDx-HR mCNPC) treated with abiraterone acetate plus prednisone (AA plus P) added to androgen deprivation therapy (ADT) 会议论文
作者:  Woo, H.;  Fizaz, K.;  Sulur, G.;  Tran, N.;  Fein, L.
收藏  |  浏览/下载：21/0  |  提交时间：2019/12/05
Clinical activity of abiraterone plus prednisone in docetaxel-naive and docetaxel-resistant Chinese patients with metastatic castration-resistant prostate cancer 期刊论文
ASIAN JOURNAL OF ANDROLOGY, 2019, 卷号: 21, 期号: 2
作者:  Lin, Guo-Wen;  Li, Gao-Xiang;  Dai, Bo;  Ye, Ding-Wei;  Kong, Yun-Yi
收藏  |  浏览/下载：13/0  |  提交时间：2019/12/05
Abiraterone acetate plus prednisone in patients with newly Croatia& diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial 期刊论文
LANCET ONCOLOGY, 2019, 卷号: 20, 期号: 5
作者:  Fizazi, Karim;  NamPhuong Tran;  Fein, Luis;  Matsubara, Nobuaki;  Rodriguez-Antolin, Alfredo
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Y08060: A Selective BET Inhibitor for Treatment of Prostate Cancer 期刊论文
ACS MEDICINAL CHEMISTRY LETTERS, 2018, 卷号: 9, 期号: 3, 页码: 262-267
作者:  Xiang, Quping;  Zhang, Yan;  Li, Jiaguo;  Xue, Xiaoqian;  Wang, Chao
收藏  |  浏览/下载：42/0  |  提交时间：2019/06/20
Androgen receptor splice variants bind to constitutively open chromatin and promote abiraterone-resistant growth of prostate cancer 期刊论文
NUCLEIC ACIDS RESEARCH, 2018, 卷号: 46, 期号: 4
作者:  Huang, Haojie;  He, Yundong;  Lu, Ji;  Ye, Zhenqing;  Hao, Siyuan
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05
Evaluation of reference-scaled average bioequivalence of two oral formulations of abiraterone acetate in healthy Chinese subjects 期刊论文
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2018, 卷号: 56, 期号: 11
作者:  Ding, Yanhua;  Li, Cuiyun;  Chen, Guiling;  Zhu, Xiaoxue;  Zhang, Hong
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05
External validation and newly development of a nomogram to predict overall survival of abiraterone-treated, castration-resistant patients with metastatic prostate cancer 期刊论文
ASIAN JOURNAL OF ANDROLOGY, 2018, 卷号: 20, 期号: 2
作者:  Yang, Yun-Jie;  Lin, Guo-Wen;  Li, Gao-Xiang;  Dai, Bo;  Ye, Ding-Wei
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05
Prior switching to a second-line nonsteroidal antiandrogen does not impact the therapeutic efficacy of abiraterone acetate in patients with metastatic castration-resistant prostate cancer: a real-world retrospective study 期刊论文
ASIAN JOURNAL OF ANDROLOGY, 2018, 卷号: Vol.20 No.6, 页码: 545-550
作者:  Zhao, Jin-Ge;  Liu, Jian-Dong;  Shen, Peng-Fei;  Tang, Xin;  Sun, Guang-Xi
收藏  |  浏览/下载：8/0  |  提交时间：2019/02/25
Androgen receptor splice variants bind to constitutively open chromatin and promote abiraterone-resistant growth of prostate cancer 期刊论文
NUCLEIC ACIDS RESEARCH, 2018, 卷号: 46, 期号: 4, 页码: 1895-1911
作者:  He, Yundong[1];  Lu, Ji[2];  Ye, Zhenqing[3];  Hao, Siyuan[4];  Wang, Liewei[5]
收藏  |  浏览/下载：14/0  |  提交时间：2019/12/24

©版权所有 ©2017 CSpace - Powered by CSpace